Skip to content

Observational Copenhagen Pancreatic Cancer Study

Copenhagen Pancreatic Cancer Study (COPAN)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06713525
Acronym
COPAN
Enrollment
8000
Registered
2024-12-03
Start date
2025-02-02
Completion date
2036-12-16
Last updated
2026-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Brief summary

The primary objective of the Copenhagen Pancreatic Cancer (COPAN) study is to describe the real-world population of patients with pancreatic cancer (PC). Larger sample of longitudinal real-world data provides a unique opportunity for comprehensive exploration of the diagnostic and treatment journey for individuals diagnosed with PC and allows to investigate treatment outcomes and associated prognostic factors. Furthermore, the study aims to identify determinants of treatment management and treatment outcomes, including patient-reported outcomes.

Detailed description

The study objective is to describe the real-world population of patients with pancreatic cancer by collecting longitudinal data that facilitates a more rigorous understanding of the PC. This research project will catalog different elements of a patient's diagnostic and treatment journey and identify unmet needs of patients with PC. The study aims to: 1. To compile detailed demographic information of patients with PC. 2. To document and analyze the clinical and disease characteristics at the time of diagnosis and beyond. 3. To track various treatment modalities employed, including surgery, chemotherapy, and radiation therapy. 4. To assess short-term and long-term outcomes, including survival rates, complications, and quality of life. 5. To identify prognostic and predictive factors within the real-world cohort. 8\. To investigate the impact of PC and treatment on patients' quality of life. 4 Study Design This study of patients with PC will employ both a prospective, observational design and retrospective design to capture real-world data relating to health status and/or the delivery of health care routinely collected from a variety of sources. Data will be collected longitudinally, allowing for a dynamic analysis of the disease trajectory.

Interventions

None listed

Sponsors

Inna Chen, MD
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Histologically confirmed pancreatic cancer

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Overall survival3 years

Countries

Denmark

Contacts

CONTACTInna Markovna Inna Markovna Chen, MD, Herlev & Gentofte Hospital, MD
Inna.Chen@regionh.dk+45 3868-2898

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 5, 2026